AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
DNA-DAMAGING EFFECTS OF PESTICIDES MEASURED BY THE SINGLE-CELL GEL-ELECTROPHORESIS ASSAY (COMET ASSAY) AND THE CHROMOSOMAL ABERRATION TEST,IN CHOK1 CELLS
Authors: VIGREUX C POUL JM DESLANDES E LEBAILLY P GODARD T SICHEL F HENRYAMAR M GAUDUCHON P
Citation: C. Vigreux et al., DNA-DAMAGING EFFECTS OF PESTICIDES MEASURED BY THE SINGLE-CELL GEL-ELECTROPHORESIS ASSAY (COMET ASSAY) AND THE CHROMOSOMAL ABERRATION TEST,IN CHOK1 CELLS, Mutation research. Genetic toxicology and environmental mutagenesis, 419(1-3), 1998, pp. 79-90
DNA-DAMAGE IN MONONUCLEAR LEUKOCYTES OF FARMERS MEASURED USING THE ALKALINE COMET ASSAY - DISCUSSION OF CRITICAL PARAMETERS AND EVALUATION OF SEASONAL-VARIATIONS IN RELATION TO PESTICIDE EXPOSURE
Authors: LEBAILLY P VIGREUX C LECHEVREL C LEDEMENEY D GODARD T SICHEL F LETALAER JY HENRYAMAR M GAUDUCHON P
Citation: P. Lebailly et al., DNA-DAMAGE IN MONONUCLEAR LEUKOCYTES OF FARMERS MEASURED USING THE ALKALINE COMET ASSAY - DISCUSSION OF CRITICAL PARAMETERS AND EVALUATION OF SEASONAL-VARIATIONS IN RELATION TO PESTICIDE EXPOSURE, Cancer epidemiology, biomarkers & prevention, 7(10), 1998, pp. 917-927
DNA-DAMAGE IN MONONUCLEAR LEUKOCYTES OF FARMERS MEASURED USING THE ALKALINE COMET ASSAY - MODIFICATIONS OF DNA-DAMAGE LEVELS AFTER A ONE-DAY FIELD SPRAYING PERIOD WITH SELECTED PESTICIDES
Authors: LEBAILLY P VIGREUX C LECHEVREL C LEDEMENEY D GODARD T SICHEL F LETALAER JY HENRYAMAR M GAUDUCHON P
Citation: P. Lebailly et al., DNA-DAMAGE IN MONONUCLEAR LEUKOCYTES OF FARMERS MEASURED USING THE ALKALINE COMET ASSAY - MODIFICATIONS OF DNA-DAMAGE LEVELS AFTER A ONE-DAY FIELD SPRAYING PERIOD WITH SELECTED PESTICIDES, Cancer epidemiology, biomarkers & prevention, 7(10), 1998, pp. 929-940
HEALTH-RELATED QUALITY-OF-LIFE AND SEQUELAE IN PATIENTS TREATED WITH BRACHYTHERAPY AND EXTERNAL-BEAM IRRADIATION FOR LOCALIZED PROSTATE-CANCER
Authors: JOLY F BRUNE D COUETTE JE LESAUNIER F HERON JF PENY J HENRYAMAR M
Citation: F. Joly et al., HEALTH-RELATED QUALITY-OF-LIFE AND SEQUELAE IN PATIENTS TREATED WITH BRACHYTHERAPY AND EXTERNAL-BEAM IRRADIATION FOR LOCALIZED PROSTATE-CANCER, Annals of oncology, 9(7), 1998, pp. 751-757
LATE COMPLICATIONS IN PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITH RECOMBINANT INTERFERON
Authors: TROUSSARD X HENRYAMAR M CARCEL C BROUSTET A MICHAUX JL MALOISEL F FEUGIER P GUILHOT F NOEL MP GARDEMBAS M FLANDRIN G
Citation: X. Troussard et al., LATE COMPLICATIONS IN PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITH RECOMBINANT INTERFERON, British Journal of Haematology, 102(1), 1998, pp. 190-190
TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE
Authors: ANDRE M HENRYAMAR M BLAISE D COLOMBAT P FLEURY J MILPIED N CAHN JY PICO JL BASTION Y KUENTZ M NEDELLEC G ATTAL M FERME C GISSELBRECHT C
Citation: M. Andre et al., TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE, Blood, 92(6), 1998, pp. 1933-1940
HEALTH-RELATED QUALITY-OF-LIFE AND SEQUELAE IN PATIENTS TREATED WITH EXTERNAL-BEAM IRRADIATION (EBI) AND BRACHYTHERAPY FOR LOCALIZED PROSTATE-CANCER (LPC)
Authors: JOLY F BRUNE D COUETTE JE HERON JF HENRYAMAR M
Citation: F. Joly et al., HEALTH-RELATED QUALITY-OF-LIFE AND SEQUELAE IN PATIENTS TREATED WITH EXTERNAL-BEAM IRRADIATION (EBI) AND BRACHYTHERAPY FOR LOCALIZED PROSTATE-CANCER (LPC), European journal of cancer, 33, 1997, pp. 137-137
PATIENTS WITH STAGE III IV HODGKINS-DISEASE IN PARTIAL REMISSION AFTER MOPP/ABV CHEMOTHERAPY HAVE EXCELLENT PROGNOSIS AFTER ADDITIONAL INVOLVED-FIELD RADIOTHERAPY - INTERIM RESULTS FROM THE ONGOING EORTC-LCG AND GPMC PHASE-III TRIAL/
Authors: RAEMAEKERS J BURGERS M HENRYAMAR M PINNA A MANDARD A MONFARDINI S HAGENBEEK A BREED W CARDE P VOVK M VANHOOF A THOMAS J NOORDIJK E
Citation: J. Raemaekers et al., PATIENTS WITH STAGE III IV HODGKINS-DISEASE IN PARTIAL REMISSION AFTER MOPP/ABV CHEMOTHERAPY HAVE EXCELLENT PROGNOSIS AFTER ADDITIONAL INVOLVED-FIELD RADIOTHERAPY - INTERIM RESULTS FROM THE ONGOING EORTC-LCG AND GPMC PHASE-III TRIAL/, Annals of oncology, 8, 1997, pp. 111-114
HODGKINS-DISEASE - LONG-TERM COMPLICATION S OF RADIOTHERAPY
Authors: COSSET JM HENRYAMAR M
Citation: Jm. Cosset et M. Henryamar, HODGKINS-DISEASE - LONG-TERM COMPLICATION S OF RADIOTHERAPY, La Presse medicale, 26(23), 1997, pp. 1107-1112
COMBINATION OF RADIOTHERAPY AND CHEMOTHERAPY IS ADVISABLE IN ALL PATIENTS WITH CLINICAL STAGE I-II HODGKINS-DISEASE, 6-YEAR RESULTS OF THE EORTC-GPMC CONTROLLED CLINICAL-TRIALS H7-VF, H7-F AND H7-U
Authors: NOORDIJK EM CARDE P HAGENBEEK A MANDARD AM KLUINNELEMANS J THOMAS J TIRELLI U MONCONDUIT M EGHBALI H BURGERS JMV DUPOUY N HENRYAMAR M
Citation: Em. Noordijk et al., COMBINATION OF RADIOTHERAPY AND CHEMOTHERAPY IS ADVISABLE IN ALL PATIENTS WITH CLINICAL STAGE I-II HODGKINS-DISEASE, 6-YEAR RESULTS OF THE EORTC-GPMC CONTROLLED CLINICAL-TRIALS H7-VF, H7-F AND H7-U, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 173-173
A PHASE-II TRIAL OF RADIOCHEMOTHERAPY WITH DAILY CARBOPLATIN, AFTER INDUCTION CHEMOTHERAPY (CARBOPLATIN AND ETOPOSIDE), IN LOCALLY ADVANCEDNONSMALL-CELL LUNG-CANCER - FINAL ANALYSIS
Authors: BARDET E RIVIERE A CHARLOUX A SPAETH D DUCOLONE A LEGROUMELLEC A PELLAECOSSET B HENRYAMAR M DOUILLARD JY
Citation: E. Bardet et al., A PHASE-II TRIAL OF RADIOCHEMOTHERAPY WITH DAILY CARBOPLATIN, AFTER INDUCTION CHEMOTHERAPY (CARBOPLATIN AND ETOPOSIDE), IN LOCALLY ADVANCEDNONSMALL-CELL LUNG-CANCER - FINAL ANALYSIS, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 163-168
ASSESSMENT OF DNA-DAMAGE INDUCED IN-VITRO BY ETOPOSIDE AND 2 FUNGICIDES (CARBENDAZIM AND CHLOROTHALONIL) IN HUMAN-LYMPHOCYTES WITH THE COMET ASSAY
Authors: LEBAILLY P VIGREUX C GODARD T SICHEL F BAR E LETALAER JY HENRYAMAR M GAUDUCHON P
Citation: P. Lebailly et al., ASSESSMENT OF DNA-DAMAGE INDUCED IN-VITRO BY ETOPOSIDE AND 2 FUNGICIDES (CARBENDAZIM AND CHLOROTHALONIL) IN HUMAN-LYMPHOCYTES WITH THE COMET ASSAY, Mutation research, 375(2), 1997, pp. 205-217
DESCRIPTIVE EPIDEMIOLOGY OF CEREBRAL GLIOMAS IN FRANCE
Authors: FLEURY A MENEGOZ F GROSCLAUDE P DAURES JP HENRYAMAR M RAVERDY N SCHAFFER P POISSON M DELATTRE JY
Citation: A. Fleury et al., DESCRIPTIVE EPIDEMIOLOGY OF CEREBRAL GLIOMAS IN FRANCE, Cancer, 79(6), 1997, pp. 1195-1202
FLOW-CYTOMETRY IN HEAD AND NECK CARCINOMA S
Authors: MICHELS JJ RAME JP DERAUCOURT D MARNAY J DUIGOU F MACELESECH J HENRYAMAR M MANDARD AM
Citation: Jj. Michels et al., FLOW-CYTOMETRY IN HEAD AND NECK CARCINOMA S, Bulletin du cancer, 84(7), 1997, pp. 693-698
FEMALE GENITAL-TRACT AND BREAST CANCERS I N FRANCE - GEOGRAPHIC REPARTITION AND ESTIMATION OF THE INCIDENCE
Authors: CHAPLAIN G GROSCLAUDE P ARVEUX P RAVERDY N MENEGOZ F HENRYAMAR M SCHAFFER P DAURES JP DEVATHAIRE F
Citation: G. Chaplain et al., FEMALE GENITAL-TRACT AND BREAST CANCERS I N FRANCE - GEOGRAPHIC REPARTITION AND ESTIMATION OF THE INCIDENCE, Bulletin du cancer, 84(10), 1997, pp. 935-940
PROGNOSTIC FACTOR TAILORED TREATMENT OF EARLY-STAGE HODGKINS-DISEASE - RESULTS FROM A PROSPECTIVE RANDOMIZED PHASE-III CLINICAL-TRIAL IN 762 PATIENTS (H7 STUDY)
Authors: HAGENBEEK A CARDE P NOORDIJK E THOMAS J TIRELLI U MONCONDUIT M EGHBALI H MANDARD AM HENRYAMAR M
Citation: A. Hagenbeek et al., PROGNOSTIC FACTOR TAILORED TREATMENT OF EARLY-STAGE HODGKINS-DISEASE - RESULTS FROM A PROSPECTIVE RANDOMIZED PHASE-III CLINICAL-TRIAL IN 762 PATIENTS (H7 STUDY), Blood, 90(10), 1997, pp. 2603-2603
DETECTION OF DNA METHYLATION ADDUCTS IN HODGKINS-DISEASE PATIENTS TREATED WITH PROCARBAZINE
Authors: BIANCHINI F WEIDERPASS E KYRTOPOULOS S SOULIOTIS VL HENRYAMAR M WILD CP BOFFETTA P
Citation: F. Bianchini et al., DETECTION OF DNA METHYLATION ADDUCTS IN HODGKINS-DISEASE PATIENTS TREATED WITH PROCARBAZINE, Biomarkers, 1(4), 1996, pp. 226-231
TREATMENT SEQUELAE AND QUALITY-OF-LIFE
Authors: HENRYAMAR M
Citation: M. Henryamar, TREATMENT SEQUELAE AND QUALITY-OF-LIFE, Bailliere's clinical haematology, 9(3), 1996, pp. 595-618
LATE COMPLICATIONS AFTER HODGKINS-DISEASE
Authors: HENRYAMAR M JOLY F
Citation: M. Henryamar et F. Joly, LATE COMPLICATIONS AFTER HODGKINS-DISEASE, Annals of oncology, 7, 1996, pp. 115-126
LATE PSYCHOSOCIAL SEQUELAE IN HODGKINS-DISEASE SURVIVORS - A FRENCH POPULATION-BASED CASE-CONTROL STUDY
Authors: JOLY F HENRYAMAR M ARVEUX P REMAN O TANGUY A PENY AM LEBAILLY P MACELESECH J VIE B GENOT JY BUSSON A TROUSSARD X LEPORRIER M
Citation: F. Joly et al., LATE PSYCHOSOCIAL SEQUELAE IN HODGKINS-DISEASE SURVIVORS - A FRENCH POPULATION-BASED CASE-CONTROL STUDY, Journal of clinical oncology, 14(9), 1996, pp. 2444-2453
PROGNOSTIC FACTORS IN ADULT PATIENTS WITH LOCALLY CONTROLLED SOFT-TISSUE SARCOMA - A STUDY OF 546 PATIENTS FROM THE FRENCH-FEDERATION-OF-CANCER-CENTERS SARCOMA GROUP
Authors: COINDRE JM TERRIER P BUI NB BONICHON F COLLIN F LEDOUSSAL V MANDARD AM VILAIN MO JACQUEMIER J DUPLAY H SASTRE X BARLIER C HENRYAMAR M LESECH JM CONTESSO G
Citation: Jm. Coindre et al., PROGNOSTIC FACTORS IN ADULT PATIENTS WITH LOCALLY CONTROLLED SOFT-TISSUE SARCOMA - A STUDY OF 546 PATIENTS FROM THE FRENCH-FEDERATION-OF-CANCER-CENTERS SARCOMA GROUP, Journal of clinical oncology, 14(3), 1996, pp. 869-877
PROGNOSTIC FACTORS FOR PATIENTS WITH LOCALIZED PRIMARY MALIGNANT FIBROUS HISTIOCYTOMA - A MULTICENTER STUDY OF 216 PATIENTS WITH MULTIVARIATE-ANALYSIS
Authors: LEDOUSSAL V COINDRE JM LEROUX A HACENE K TERRIER P BUI NB BONICHON F COLLIN F MANDARD AM CONTESSO G HENRYAMAR M MACELESECH J VILAIN MO JACQUEMIER J DUPLAY H SASTRE X
Citation: V. Ledoussal et al., PROGNOSTIC FACTORS FOR PATIENTS WITH LOCALIZED PRIMARY MALIGNANT FIBROUS HISTIOCYTOMA - A MULTICENTER STUDY OF 216 PATIENTS WITH MULTIVARIATE-ANALYSIS, Cancer, 77(9), 1996, pp. 1823-1830
SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES - CLINICAL PRESENTATION, BIOLOGY AND PROGNOSTIC FACTORS IN A SERIES OF 100 PATIENTS
Authors: TROUSSARD X VALENSI F DUCHAYNE E GARAND R FELMAN P TULLIEZ M HENRYAMAR M BRYON PA FLANDRIN G
Citation: X. Troussard et al., SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES - CLINICAL PRESENTATION, BIOLOGY AND PROGNOSTIC FACTORS IN A SERIES OF 100 PATIENTS, British Journal of Haematology, 93(3), 1996, pp. 731-736
COMBINED-MODALITY TREATMENT VS CHEMOTHERAPY ALONE IN HODGKINS-DISEASE(HD) - AN OVERVIEW ON RANDOMIZED TRIALS
Authors: LOEFFLER M BROSTEANU O HASENCLEVER D SEXTRO M COSSET J DAHLBERG S FISHER R GRAY R HENRYAMAR M HOPPE R SOMERS R SPECHT L
Citation: M. Loeffler et al., COMBINED-MODALITY TREATMENT VS CHEMOTHERAPY ALONE IN HODGKINS-DISEASE(HD) - AN OVERVIEW ON RANDOMIZED TRIALS, Blood, 88(10), 1996, pp. 353-353
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IMPROVES SURVIVAL OF REFRACTORY HODGKINS-DISEASE (HD) PATIENTS - A RETROSPECTIVE MATCH-CONTROLLED STUDY
Authors: ANDRE M HENRYAMAR M PICO JL BASTION Y BLAISE D KUENTZ M COLOMBAT P CAHN JY ATTAL M FLEURY J MILPIED N BIRON P NEDELLEC G JOUET JP TILLY R FERME C GISSELBRECHT C
Citation: M. Andre et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IMPROVES SURVIVAL OF REFRACTORY HODGKINS-DISEASE (HD) PATIENTS - A RETROSPECTIVE MATCH-CONTROLLED STUDY, Blood, 88(10), 1996, pp. 479-479
Risultati: 1-25 | 26-48